Cormorant Asset Management, LP - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,285,960
-62.9%
1,087,8070.0%0.25%
-61.4%
Q2 2023$11,563,388
+127517.1%
1,087,8070.0%0.65%
+8.5%
Q1 2023$9,061
-9.8%
1,087,8070.0%0.60%
-11.2%
Q4 2022$10,040
-99.9%
1,087,8070.0%0.67%
-31.1%
Q3 2022$13,967,000
-2.8%
1,087,8070.0%0.98%
-10.2%
Q2 2022$14,370,000
-37.2%
1,087,8070.0%1.09%
-38.2%
Q1 2022$22,898,000
-19.3%
1,087,807
-8.0%
1.76%
+4.2%
Q4 2021$28,365,000
-12.8%
1,182,362
-7.5%
1.69%
+27.7%
Q3 2021$32,519,000
-24.4%
1,278,2760.0%1.32%
-9.6%
Q2 2021$43,027,000
-23.0%
1,278,276
-11.1%
1.46%
+17.5%
Q1 2021$55,844,000
-37.3%
1,437,8070.0%1.24%
-41.3%
Q4 2020$89,043,000
+72.9%
1,437,807
-6.5%
2.12%
+7.0%
Q3 2020$51,501,000
+27.0%
1,537,807
-9.6%
1.98%
+28.0%
Q2 2020$40,542,000
+3.5%
1,701,292
-0.5%
1.55%
-15.0%
Q1 2020$39,154,000
-22.7%
1,709,765
-4.4%
1.82%
-10.0%
Q4 2019$50,654,000
+31.8%
1,788,643
+0.0%
2.02%
-13.6%
Q3 2019$38,433,000
-29.5%
1,788,394
-4.3%
2.34%
-25.3%
Q2 2019$54,539,0001,869,6803.13%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 17,161,713$666,561,00074.20%
RTW INVESTMENTS, LP 3,644,248$141,543,0002.21%
Redmile Group, LLC 2,544,062$98,811,0001.39%
Cormorant Asset Management, LP 1,437,807$55,844,0001.24%
ACUTA CAPITAL PARTNERS, LLC 45,000$1,748,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 150,729$5,854,0000.45%
HighVista Strategies LLC 13,692$532,0000.40%
Birchview Capital, LP 15,000$583,0000.35%
Perceptive Advisors 671,978$26,100,0000.33%
GILDER GAGNON HOWE & CO LLC 1,265,950$49,169,0000.26%
View complete list of STOKE THERAPEUTICS INC shareholders